Empagliflozin 10 MG
2023-GSP-GG-18
Approved small_molecule active
Quick answer
Empagliflozin 10 MG for Pre-Heart Failure is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Pre-Heart Failure
- Phase
- Approved
- Modality
- small_molecule
- Status
- active